OBJECTIVE: To evaluate the risk factors for failure of continuous veno-venous hemodialysis (CVVHD) in the treatment of acute renal failure (ARF) after cardiac surgery. METHODS: Adult patients without any prior pre-operative history of chronic renal failure who underwent CVVHD after cardiac surgery in our medical center from January 2005 to December 2008 were divided into a success or a failure group. All selected patients' pre-, intra-, and post-operative data were retrospectively analyzed. ARF was described as post-operative urinary output of less than 0.5ml/kg/h and/or a 50% increase in baseline BUN and serum creatinine levels. RESULTS: Fifty-two adult patients (accounting for 3.04%) who underwent CVVHD after cardiac surgery were entered into this study. Thirty-six patients survived, with a mortality rate of 30.8%. Pre-operative mean left ventricular ejection fraction (LVEF) in the success group was higher than that in the failure group (46±9% versus 40±7%, p=0.0220). Mean duration of oliguria until dialysis in the failure group was significantly longer than that in the success group (22.1±6.9h versus 11.6±2.5h, p<0.0001). Through univariate analysis and multivariate logistic regression, independent risk factors for failure of CVVHD in the treatment of post-operative ARF included pre-operative LVEF (OR=0.635, 95% CI 0.358-0.852) and duration of oliguria until dialysis (OR=2.442, 95% CI 1.563-5.768). CONCLUSIONS: Pre-operative impaired left ventricular function is an important risk factor for failure of CVVHD in the treatment of ARF after cardiac surgery. The sooner CVVHD is instituted the better prognosis may be.
OBJECTIVE: To evaluate the risk factors for failure of continuous veno-venous hemodialysis (CVVHD) in the treatment of acute renal failure (ARF) after cardiac surgery. METHODS: Adult patients without any prior pre-operative history of chronic renal failure who underwent CVVHD after cardiac surgery in our medical center from January 2005 to December 2008 were divided into a success or a failure group. All selected patients' pre-, intra-, and post-operative data were retrospectively analyzed. ARF was described as post-operative urinary output of less than 0.5ml/kg/h and/or a 50% increase in baseline BUN and serum creatinine levels. RESULTS: Fifty-two adult patients (accounting for 3.04%) who underwent CVVHD after cardiac surgery were entered into this study. Thirty-six patients survived, with a mortality rate of 30.8%. Pre-operative mean left ventricular ejection fraction (LVEF) in the success group was higher than that in the failure group (46±9% versus 40±7%, p=0.0220). Mean duration of oliguria until dialysis in the failure group was significantly longer than that in the success group (22.1±6.9h versus 11.6±2.5h, p<0.0001). Through univariate analysis and multivariate logistic regression, independent risk factors for failure of CVVHD in the treatment of post-operative ARF included pre-operative LVEF (OR=0.635, 95% CI 0.358-0.852) and duration of oliguria until dialysis (OR=2.442, 95% CI 1.563-5.768). CONCLUSIONS: Pre-operative impaired left ventricular function is an important risk factor for failure of CVVHD in the treatment of ARF after cardiac surgery. The sooner CVVHD is instituted the better prognosis may be.